SONM

DNA X, Inc.
—

Company Information

Company Name
DNA X, Inc.
CIK
CIK0001178697
Category
Non-accelerated filer<br>Smaller reporting company
Ticker: Exchange
SONM: Nasdaq
Fiscal Year End
December 31
Owner Organization
04 Manufacturing
SIC
3661
SIC Description
Telephone & Telegraph Apparatus
Ticker
SONM

SEC filing data through

Insider Sentiment

Last purchase
2023-09-15
Last sale
2025-06-30
Shares purchased (TTM)
0
Shares sold (TTM)
529,960
Buy ratio (TTM)0.0%

Institutional Sentiment

As of
2026-06-30
Institutional shares owned
88,387
Shares outstanding
1,350,914
Ownership
6.54%
-31.91% Y/Y

Earnings Market Reaction

Filing date
2026-08-19
Price on filing date
—
1-month reaction
…
3-month reaction
…
Drift continued5/10 (50%)
Faded / reversed5/10 (50%)

Balance Sheet

Values in millions ($)
Line item2026-06-302026-03-312025-12-312025-09-302025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-30Subscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnSubscriber-only columnTrend
Cash And Cash Equivalents At Carrying Value11122259109910
Accounts Receivable Net Current---3354511132530
Nontrade Receivables Current---1076742112
Other Receivables Net Current----0001----
Inventory Net---1110911127574
Receivables Net Current12----------
Prepaid Expense And Other Assets Current111455523222
Assets Held For Sale Not Part Of Disposal Group Current--27---27-----
Assets
Assets5544403636404946425659
Assets Current3329302727323433304448
Property Plant And Equipment Net---000000000
Operating Lease Right Of Use Asset----------00
Contract With Customer Asset Net Noncurrent-----------8
Capitalized Contract Cost Net---98861210109-
Deferred Income Tax Assets Net--1---0-----
Finite Lived Intangible Assets Net1-----------
Other Assets Noncurrent000111033333
Debt Securities Held To Maturity Amortized Cost After Allowance For Credit Loss Noncurrent--12---7-----
Long Term Debt Current-----------0
Accounts Payable Current11420211719992023
Accrued Liabilities Current12114121502318121211
Contract With Customer Liability Current--------0000
Notes Payable-----2------
Notes Payable Current--553-------
Derivative Liabilities Current100---------
Liabilities Of Disposal Group Including Discontinued Operation Current--38---43-----
Accrued Income Taxes013222222221
Liabilities And Stockholders Equity
Liabilities And Stockholders Equity5544403636404946425659
Operating Lease Liability Current----------00
Liabilities Current5448393635443227213234
Long Term Notes Payable---0-1------
Liabilities6551413737453428233436
Temporary Equity Carrying Amount Attributable To Parent-11---------
Common Stock Value000000000000
Stockholders Equity
Additional Paid In Capital298297296295289282278277277273272272
Stockholders Equity-1-1-8-1-1-1-61517202223
Retained Earnings Accumulated Deficit-299-298-304-295-291-283-284-262-259-253-250-249
Temporary Equity Par Or Stated Value Per Share0.000.000.00---0.00-----
Temporary Equity Shares Issued000---------
Temporary Equity Shares Outstanding000---------
Redeemable Noncontrolling Interest Equity Common Redemption Value--0---------
Temporary Equity Liquidation Preference11----------
Common Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.00-
Common Stock Shares Authorized1,0001,0001,0001001001001,000100100100100-
Common Stock Shares Issued1111106055434-
Shares Outstanding111110605543443
Preferred Stock Par Or Stated Value Per Share0.000.000.000.000.000.000.000.000.000.000.00-
Preferred Stock Shares Authorized55555555555-
Preferred Stock Shares Issued00000000000-
Preferred Stock Shares Outstanding00000000000-

Select a line item above to chart it.

Recent filings

Financial statements beyond 3 years are for subscribers only.

Unlock 17+ years of income statements, balance sheets, and cash flow statements

Start 7-day free trial

DNA X, Inc. (SONM) — SEC Financial Statements & Analysis

DNA X, Inc. (SONM) is a telephone & telegraph apparatus company, incorporated in DE. DNA X, Inc. trades on Nasdaq as: SONM. DNA X, Inc. (SONM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19. Based on that filing, DNA X, Inc. carries a market cap of $6.96M, a P/E ratio of -0.81x, a P/B ratio of -5.65x, a P/S ratio of 0.43x, an enterprise value of $6.06M, and an EV/EBITDA multiple of -1.13x. On profitability, it posts a gross margin of 16.23%, an operating margin of -49.10%, a net margin of -52.71%, a Return on Equity (ROE) of 666.17%, a Return on Assets (ROA) of -42.11%, and a Return on Invested Capital (ROIC) of 39.02%. Per share, it reports EPS of $-6.33, diluted EPS of $-6.33, free cash flow per share of $-10.74, and a dividend per share of $0.00. Over the trailing year, it posted revenue growth of -75.27% year-over-year, net income growth of -72.56% year-over-year, and EPS growth of -89.27% year-over-year. On the balance sheet, it maintains a current ratio of 0.57x, a quick ratio of 0.42x, working capital of $-2.23M, a debt-to-equity ratio of -4.67x, a debt ratio of 1.27, an interest coverage ratio of -6.23x, free cash flow of $-14.51M (TTM), and net debt of $-900.00K. Figures sourced from SEC EDGAR.

Market Cap
$6.96M
P/E TTM
-0.81x
EPS TTM
$-6.33
P/B TTM
-5.65x
ROE TTM
666.17%
ROA TTM
-42.11%
Debt To Equity
-4.67x
Free Cash Flow TTM
$-14.51M
Net Revenue TTM Growth 1Y
-75.27%

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is DNA X, Inc. in?

DNA X, Inc. (SONM) operates in the Telephone & Telegraph Apparatus industry.

What exchange does SONM trade on?

DNA X, Inc. (SONM) trades on the Nasdaq.

Where is DNA X, Inc. incorporated?

DNA X, Inc. is incorporated in DE.

When was DNA X, Inc. (SONM)'s most recent SEC filing?

DNA X, Inc. (SONM)'s most recent SEC filing is a Form 10-Q for the period ended 2026-06-30, filed with the SEC on 2026-08-19.

What is SONM's market cap?

DNA X, Inc. (SONM) has a market capitalization of $6.96M as of 2026-06-30.

What is SONM's EPS (earnings per share)?

DNA X, Inc. (SONM)'s trailing twelve month EPS is $-6.33 as of 2026-06-30.

What is SONM's ROE (return on equity)?

DNA X, Inc. (SONM)'s trailing twelve month Return on Equity (ROE) is 666.17% as of 2026-06-30.

What is SONM's ROA (return on assets)?

DNA X, Inc. (SONM)'s trailing twelve month Return on Assets (ROA) is -42.11% as of 2026-06-30.

What is SONM's ROIC (return on invested capital)?

DNA X, Inc. (SONM)'s trailing twelve month Return on Invested Capital (ROIC) is 39.02% as of 2025-09-30.

What is SONM's EV/EBITDA?

DNA X, Inc. (SONM)'s trailing twelve month EV/EBITDA is -1.13x as of 2026-06-30.

Wall Street's data.
Main Street's price.